Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors. [electronic resource]
- Transplantation Dec 1990
- 964-8 p. digital
Publication Type: Journal Article
0041-1337
10.1097/00007890-199012000-00013 doi
Blood Donors Blood Transfusion Bone Marrow--microbiology Bone Marrow Transplantation--adverse effects Cytomegalovirus Infections--prevention & control Erythrocyte Transfusion Graft vs Host Disease--prevention & control Humans Platelet Transfusion Transplantation, Homologous